Nabiximols:Written question - 1564

Q
Asked by Steve McCabe
(Birmingham, Selly Oak)
Asked on: 09 June 2015
Department of Health
Nabiximols
Commons
To ask the Secretary of State for Health, whether he plans to allow routine access on the NHS in England to the medicine Sativex.
A
Answered by: George Freeman
Answered on: 17 June 2015

The National Institute for Health and Care Excellence (NICE) published a clinical guideline on multiple sclerosis in 2014 that does not recommend Sativex (nabiximols) as a clinically and cost effective use of National Health Service resources. This is available at:

www.nice.org.uk/guidance/cg186/chapter/1-recommendations

Therefore we have no plans to ask NICE to carry out a technology appraisal of Sativex for the treatment of spasticity in multiple sclerosis.

It is for commissioners to decide whether to fund this treatment for individual patients.

Grouped Questions: 1563 | 1565 | 1566

Share this page